( OTC-QB:BRRY,OTC-QB:DMPI )

News from delmar pharmaceuticals A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Sep 28, 2015, 09:00 ET OTC Markets Group to Host Virtual Investor Conference for OTCQX Life Science Companies - October 1

 OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial markets for 10,000 U.S. and global securities,...


Feb 26, 2014, 08:00 ET DelMar Pharmaceuticals Provides Update on VAL-083 Glioblastoma Clinical Trial

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") provided an update on the company's ongoing Phase I/II clinical trial for...


Nov 11, 2013, 08:00 ET DelMar Pharmaceuticals Gives Quarterly Shareholder Update

Dear Shareholders and Friends of DelMar Pharmaceuticals: I am pleased to provide you with an update as of the quarter ended September 30, 2013 and...


Oct 15, 2013, 08:00 ET DelMar Pharmaceuticals to Present at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Annual Meeting

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" or "DelMar Pharma") today announced that the company would present an abstract entitled...


Oct 09, 2013, 08:00 ET DelMar Pharma talks to Life Sciences IP Review (LSIPR) about creating new patents for shelved drugs to streamline path to patients

 The president and CEO of DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar Pharma" or "DelMar") Jeffrey Bacha spoke to Life Science IP...